<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">PDE </span>
   <span class="font26">EISO </span>
   <span class="font18">activity </span>
   <span class="font18">&amp;lt; </span>
   <span class="font18">expression </span>
   <span class="font16">inflammatory </span>
   <span class="font16">skin </span>
   <span class="font15">LPS </span>
   <span class="font15">cells </span>
   <span class="font15">cAMP </span>
   <span class="font15">treatment </span>
   <span class="font14">levels </span>
   <span class="font14">cell </span>
   <span class="font14">NF-κB </span>
   <span class="font13">{border-style </span>
   <span class="font13">Figure </span>
   <span class="font13">United </span>
   <span class="font13">patients </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">phosphodiesterase </span>
   <span class="font13">LPS-stimulated </span>
   <span class="font13">sandalwood </span>
   <span class="font12">THP- </span>
   <span class="font12">using </span>
   <span class="font12">human </span>
   <span class="font12">oil </span>
   <span class="font12">psoriatic </span>
   <span class="font12">suppressed </span>
   <span class="font12">versus </span>
   <span class="font12">Indian </span>
   <span class="font12">Sharma </span>
   <span class="font12">activation </span>
   <span class="font12">atopic </span>
   <span class="font12">chronic </span>
   <span class="font12">results </span>
   <span class="font12">Dermatol. </span>
   <span class="font12">East </span>
   <span class="font12">Schafer </span>
   <span class="font12">anti-inflammatory </span>
   <span class="font12">protein </span>
   <span class="font12">Immunol. </span>
   <span class="font12">cells. </span>
   <span class="font12">lung </span>
   <span class="font12">topical </span>
   <span class="font12">treated </span>
   <span class="font11">IBMX </span>
   <span class="font11">assessed </span>
   <span class="font11">clinical </span>
   <span class="font11">hydrolysis </span>
   <span class="font11">increased </span>
   <span class="font11">model </span>
   <span class="font11">./j.-...x </span>
   <span class="font11">PDEB </span>
   <span class="font11">cancer </span>
   <span class="font11">cyclic </span>
   <span class="font11">p-p </span>
   <span class="font11">production </span>
   <span class="font11">suppress </span>
   <span class="font11">ability </span>
   <span class="font11">acute </span>
   <span class="font11">assay </span>
   <span class="font11">control </span>
   <span class="font11">described </span>
   <span class="font11">induced </span>
   <span class="font11">psoriasis </span>
   <span class="font11">px; </span>
   <span class="font11">response </span>
   <span class="font11">rolipram </span>
   <span class="font11">shown </span>
   <span class="font11">stratum </span>
   <span class="font11">used </span>
   <span class="font11">{font-family </span>
   <span class="font11">BEAS-B, </span>
   <span class="font11">FIGURE </span>
   <span class="font11">IL- </span>
   <span class="font11">Inc. </span>
   <span class="font11">Pharmacol. </span>
   <span class="font11">States). </span>
   <span class="font11">Ther. </span>
   <span class="font11">brain </span>
   <span class="font11">dermatitis </span>
   <span class="font11">disorders </span>
   <span class="font11">font-size </span>
   <span class="font11">immune </span>
   <span class="font11">inhibition </span>
   <span class="font11">inhibitor </span>
   <span class="font11">properties </span>
   <span class="font11">reduction </span>
   <span class="font11">reverse, </span>
   <span class="font11">therapeutic </span>
   <span class="font11">total </span>
   <span class="font11">vehicle </span>
   <span class="font11">††† </span>
   <span class="font11">∗∗∗ </span>
   <span class="font11">(), </span>
   <span class="font11">BEAS-B </span>
   <span class="font11">COPD </span>
   <span class="font11">Clin. </span>
   <span class="font11">EASI </span>
   <span class="font11">LPS-induced </span>
   <span class="font11">Oger </span>
   <span class="font11">PDEs </span>
   <span class="font11">Pharmaceuticals, </span>
   <span class="font11">SEM </span>
   <span class="font11">Santalis </span>
   <span class="font11">activity, </span>
   <span class="font11">antibody </span>
   <span class="font11">cellular </span>
   <span class="font11">control; </span>
   <span class="font11">determined </span>
   <span class="font11">double; </span>
   <span class="font11">effects </span>
   <span class="font11">forward, </span>
   <span class="font11">impact </span>
   <span class="font11">keratinocytes </span>
   <span class="font11">kinase </span>
   <span class="font11">lysates </span>
   <span class="font11">mean </span>
   <span class="font11">models </span>
   <span class="font11">observed </span>
   <span class="font11">proinflammatory </span>
   <span class="font11">provided </span>
   <span class="font11">responses </span>
   <span class="font11">samples </span>
   <span class="font11">study </span>
   <span class="font11">transcriptional </span>
   <span class="font11">vitro </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">AD, </span>
   <span class="font10">Allergy </span>
   <span class="font10">Am. </span>
   <span class="font10">Cells </span>
   <span class="font10">DF, </span>
   <span class="font10">Expression </span>
   <span class="font10">Guttman-Yassky </span>
   <span class="font10">IL-, </span>
   <span class="font10">Krueger </span>
   <span class="font10">LPS-mediated </span>
   <span class="font10">Levenson </span>
   <span class="font10">PDEA, </span>
   <span class="font10">Phase </span>
   <span class="font10">Phosphodiesterase </span>
   <span class="font10">Res. </span>
   <span class="font10">Smith </span>
   <span class="font10">adverse </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">bovine </span>
   <span class="font10">cells, </span>
   <span class="font10">conditions </span>
   <span class="font10">cytokine/chemokine </span>
   <span class="font10">dermal </span>
   <span class="font10">dermatitis. </span>
   <span class="font10">directly </span>
   <span class="font10">diseases. </span>
   <span class="font10">distribution </span>
   <span class="font10">epithelial </span>
   <span class="font10">expressed </span>
   <span class="font10">factors </span>
   <span class="font10">indicate </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitor, </span>
   <span class="font10">key </span>
   <span class="font10">known </span>
   <span class="font10">lipopolysaccharide </span>
   <span class="font10">mRNA </span>
   <span class="font10">new </span>
   <span class="font10">normal </span>
   <span class="font10">novel </span>
   <span class="font10">nucleotide </span>
   <span class="font10">pediatric </span>
   <span class="font10">previously </span>
   <span class="font10">primary </span>
   <span class="font10">psoriasis. </span>
   <span class="font10">pulmonary </span>
   <span class="font10">reported </span>
   <span class="font10">severity </span>
   <span class="font10">solid; </span>
   <span class="font10">stimulation </span>
   <span class="font10">suggest </span>
   <span class="font10">suppresses </span>
   <span class="font10">transcript </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(C) </span>
   <span class="font10">(v/v) </span>
   <span class="font10">Acad. </span>
   <span class="font10">Biochem. </span>
   <span class="font10">Bommareddy </span>
   <span class="font10">Browning </span>
   <span class="font10">CA, </span>
   <span class="font10">Clinical </span>
   <span class="font10">Cox </span>
   <span class="font10">Cyclic </span>
   <span class="font10">Data </span>
   <span class="font10">MCP-, </span>
   <span class="font10">Materials </span>
   <span class="font10">PDE-selective </span>
   <span class="font10">Physiol. </span>
   <span class="font10">Schafer, </span>
   <span class="font10">Sci. </span>
   <span class="font10">Seybold </span>
   <span class="font10">Skin </span>
   <span class="font10">Suppresses </span>
   <span class="font10">Wright </span>
   <span class="font10">Zhang </span>
   <span class="font10">activation, </span>
   <span class="font10">airway </span>
   <span class="font10">antagonize </span>
   <span class="font10">basal </span>
   <span class="font10">basalis </span>
   <span class="font10">bold </span>
   <span class="font10">changes </span>
   <span class="font10">comparable </span>
   <span class="font10">conducted </span>
   <span class="font10">courier; </span>
   <span class="font10">cytokines </span>
   <span class="font10">development </span>
   <span class="font10">disease </span>
   <span class="font10">eczema </span>
   <span class="font10">effect </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">enzymatic </span>
   <span class="font10">exhibited </span>
   <span class="font10">hydrolyzing </span>
   <span class="font10">imaged </span>
   <span class="font10">including </span>
   <span class="font10">increase </span>
   <span class="font10">kit </span>
   <span class="font10">layers </span>
   <span class="font10">media </span>
   <span class="font10">moderate </span>
   <span class="font10">nuclear </span>
   <span class="font10">obstructive </span>
   <span class="font10">pathology </span>
   <span class="font10">patient </span>
   <span class="font10">potential </span>
   <span class="font10">pt;} </span>
   <span class="font10">regimen </span>
   <span class="font10">report </span>
   <span class="font10">safety </span>
   <span class="font10">selective </span>
   <span class="font10">severe </span>
   <span class="font10">stress </span>
   <span class="font10">studies </span>
   <span class="font10">suppressing </span>
   <span class="font10">suppression </span>
   <span class="font10">transcription </span>
   <span class="font10">upregulated </span>
   <span class="font10">μg/ml) </span>
  </p>
 </body>
</html>
